GlassScriptPhysician profile
Chelsea Lee Willis
NPI 1942655154
$824.21
in general payments reported to CMS, 2019-2025
18 companies · $69.84 in 2025
The $69.84 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $163 · 2021: $94.97 · 2022: $31.30 · 2023: $167 · 2024: $103 · 2025: $69.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.44 | 2019-2023 | Wegovy |
| Abbvie INC. | $125.23 | 2023-2025 | Ubrelvy |
| Lilly USA, LLC | $109.11 | 2019-2023 | Mounjaro, Jardiance |
| Abbott Laboratories | $103.44 | 2023-2024 | Freestyle Libre 3 |
| Astellas Pharma US INC | $47.35 | 2019-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $44.79 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $38.16 | 2019-2021 | |
| Amarin Pharma, INC. | $36.21 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $34.83 | 2019-2020 | |
| Pfizer INC. | $30.71 | 2020-2023 | |
| Glaxosmithkline, LLC. | $24.42 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.36 | 2019 | |
| Hikma Pharmaceuticals USA | $15.35 | 2020 | |
| Gilead Sciences, INC. | $13.71 | 2020 | |
| Vanda Pharmaceuticals INC. | $13.33 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.58 | 2021 | |
| Endo Pharmaceuticals INC. | $12.11 | 2020 | |
| Currax Pharmaceuticals LLC | $4.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.